{"id":369819,"date":"2021-02-12T22:06:14","date_gmt":"2021-02-13T06:06:14","guid":{"rendered":"https:\/\/nai500.com\/blog\/2021\/02\/g1-therapeutics-jumps-16-9-as-trilaciclib-wins-fda-approval-bionano-genomics-shares-hit-all-time-high-spiking-nearly-23\/"},"modified":"2021-02-12T22:07:04","modified_gmt":"2021-02-13T06:07:04","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-g1-therapeutics-%e5%a4%a7%e6%b6%a8-bionano-genomics-%e8%82%a1%e4%bb%b7%e5%88%9b%e5%8e%86%e5%8f%b2%e6%96%b0%e9%ab%98","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2021\/02\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be%e9%80%89-g1-therapeutics-%e5%a4%a7%e6%b6%a8-bionano-genomics-%e8%82%a1%e4%bb%b7%e5%88%9b%e5%8e%86%e5%8f%b2%e6%96%b0%e9%ab%98\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014G1 Therapeutics\u5927\u6da816.9%\uff1bBionano Genomics\u80a1\u4ef7\u521b\u5386\u53f2\u65b0\u9ad8"},"content":{"rendered":"

G1 Therapeutics<\/strong>\u5927\u6da816.9%<\/strong><\/h2>\n

G1 Therapeutics(NASDAQ:GTHX<\/a>)\u76d8\u540e\u5927\u6da816.9%\uff0c\u6b64\u524dFDA\u6279\u51c6\u8be5\u516c\u53f8\u7684Cosela(trilaciclib)\u4e3a\u540c\u7c7b\u7597\u6cd5\u4e2d\u9996\u4e2a “\u964d\u4f4e\u5e7f\u6cdb\u671f(\u5f53\u764c\u75c7\u5df2\u6269\u6563\u81f3\u80ba\u90e8\u4ee5\u5916)\u5c0f\u7ec6\u80de\u80ba\u764c\u63a5\u53d7\u67d0\u4e9b\u7c7b\u578b\u5316\u7597\u7684\u6210\u5e74\u4eba\u5316\u7597\u5f15\u8d77\u7684\u9aa8\u9ad3\u6291\u5236\u9891\u7387”\u7684\u7597\u6cd5\u3002<\/p>\n

FDA\u8bf4\uff0cCosela\u53ef\u80fd\u901a\u8fc7\u6291\u5236\u7ec6\u80de\u5468\u671f\u86cb\u767d\u4f9d\u8d56\u6027\u6fc0\u91764\/6\uff08\u4e00\u79cd\u9176\uff09\u6765\u5e2e\u52a9\u4fdd\u62a4\u9aa8\u9ad3\u7ec6\u80de\u514d\u53d7\u5316\u5b66\u7597\u6cd5\u7684\u635f\u5bb3\u3002<\/p>\n

Cosela\u83b7\u5f97\u4e86FDA\u7684\u4f18\u5148\u5ba1\u67e5\u548c\u7a81\u7834\u6027\u7597\u6cd5\u79f0\u53f7\u3002<\/p>\n

Bionano Genomics<\/strong>\u80a1\u4ef7\u521b\u5386\u53f2\u65b0\u9ad8<\/strong><\/h2>\n

Bionano Genomics\uff08NASDAQ:BNGO<\/a>\uff09\u7684\u80a1\u4ef7\u4eca\u5929\u4e0b\u5348\u521b\u4e0b\u5386\u53f2\u65b0\u9ad8\uff0c\u9996\u6b21\u7a81\u783414\u7f8e\u5143\u5173\u53e3\u3002<\/p>\n

\u5728\u8fc7\u53bb\u768430\u5929\u91cc\uff0c\u80a1\u4ef7\u5df2\u7ecf\u7ffb\u4e86\u4e00\u500d\u591a\uff0c\u4e0a\u6da8\u4e86106%\u3002<\/p>\n

\u4ec5\u4eca\u5929\u4e0b\u5348\u7684\u4ea4\u6613\u4e2d\uff0c\u80a1\u4ef7\u5c31\u4e0a\u6da8\u4e8622.8%\u81f314.37\u7f8e\u5143\u3002<\/p>\n

\u4eca\u5929\u4e0a\u5348\u53d1\u8868\u7684\u4e00\u7bc7\u6587\u7ae0\u8c08\u5230\u4e86\u8be5\u516c\u53f8Saphyr\u57fa\u56e0\u7ec4\u6210\u50cf\u7cfb\u7edf\u7684\u91cd\u8981\u6027\u3002<\/p>\n

\u6587\u7ae0\u8bf4\uff1a”\u7814\u7a76\u4eba\u5458\u6b63\u5728\u4f7f\u7528Saphyr\u7cfb\u7edf\u6765\u589e\u52a0\u4ed6\u4eec\u5bf9\u4f7f\u67d0\u4e9b\u80bf\u7624\u5177\u6709\u653b\u51fb\u6027\u7684\u57fa\u56e0\u7ec4\u7ed3\u6784\u7684\u7406\u89e3\u3002\u901a\u8fc7\u8fdb\u884c\u8fd9\u6837\u7684\u7814\u7a76\uff0c\u7814\u7a76\u4eba\u5458\u5c06\u80fd\u591f\u5f00\u53d1\u51fa\u6709\u9488\u5bf9\u6027\u7684\u7597\u6cd5\uff0c\u66f4\u597d\u5730\u5bf9\u764c\u75c7\u4e9a\u578b\u8fdb\u884c\u5206\u7c7b\uff0c\u5e76\u4f7f\u73b0\u6709\u7684\u764c\u75c7\u6cbb\u7597\u66f4\u52a0\u6709\u6548\u3002”<\/p>\n

\u4eca\u5e741\u6708\uff0cBionano\u80a1\u4ef7\u66b4\u6da8\uff0c\u6b64\u524d\u53d1\u8868\u7684\u4e00\u9879\u7814\u7a76\u663e\u793a\uff0cSaphyr\u7684\u5149\u5b66\u57fa\u56e0\u7ec4\u56fe\u8c31\u53d1\u73b0\u4e86\u7ed3\u6784\u53d8\u5f02\uff0c\u8fd9\u4e9b\u53d8\u5f02\u5f71\u54cd\u4e86\u63a7\u5236\u514d\u75ab\u548c\u708e\u75c7\u53cd\u5e94\u3001\u75c5\u6bd2\u7e41\u6b96\u548c\u7c98\u819c\u529f\u80fd\u7684\u9014\u5f84\u4e2d\u7684\u57fa\u56e0\uff0c\u8fd9\u53ef\u4ee5\u6709\u52a9\u4e8e\u4e86\u89e3COVID-19\u7684\u53d1\u75c5\u673a\u5236\u3002<\/p>\n

\u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0c\u8be5\u516c\u53f8\u62a5\u544a\u8bf4\uff0c\u591a\u4f26\u591a\u7684\u5927\u5b66\u5065\u5eb7\u7f51\u7edc\u7684\u5b9e\u9a8c\u5ba4\u533b\u5b66\u9879\u76ee\uff08\u52a0\u62ff\u5927\u6700\u5927\u7684\u533b\u9662\u8bca\u65ad\u6d4b\u8bd5\u5b9e\u9a8c\u5ba4\uff09\u5df2\u7ecf\u5f00\u59cb\u8bd5\u70b9Saphyr\u3002<\/p>\n

FDA<\/strong>\u6279\u51c6NantKwest<\/strong>\u6269\u5927COVID-19<\/strong>\u75ab\u82d7\u76841<\/strong>\u671f\u8bd5\u9a8c\uff0c\u80a1\u4ef7\u5927\u6da8<\/strong><\/h2>\n

NantKwest, Inc. (NASDAQ:NK<\/a>)\u76d8\u524d\u4e0a\u6da812.9%\uff0c\u6b64\u524d\u8be5\u516c\u53f8\u53ca\u5176\u79c1\u8425\u5408\u4f5c\u4f19\u4f34ImmunityBio\u5ba3\u5e03FDA\u6279\u51c6\u6269\u5927\u8be5\u516c\u53f8\u57fa\u4e8eT\u7ec6\u80de\u7684\u5019\u9009\u65b0\u51a0\u75ab\u82d7\u7684I\u671f\u7814\u7a76\u3002<\/p>\n

\u8bc4\u4f30\u5b9e\u9a8c\u6027\u4e8c\u4ef7hAd5 T\u7ec6\u80de\u65b0\u51a0\u75c5\u6bd2\u76ae\u4e0b\u7248\u672c\u7684\u4e00\u671f\u8bd5\u9a8c\u7684C\u7ec4\u8bd5\u9a8c\u5f97\u5230\u6269\u5bb9\uff0c\u5c06\u589e\u52a0\u820c\u4e0b\u589e\u6548\u5242\u7684\u6548\u679c\u3002<\/p>\n

\u800c\u7b2c\u4e8c\u9879I\u671f\u7814\u7a76\u4e5f\u5c06\u5f00\u59cb\u5728\u8bc4\u4f30\u76ae\u4e0b\u539f\u6db2\u7ed9\u836f\u7684\u57fa\u7840\u4e0a\u589e\u52a0\u53e3\u670d\u589e\u6548\u5242\u7684\u6548\u679c\u3002<\/p>\n

\u6839\u636e\u4fee\u6539\u540e\u7684\u8bd5\u9a8c\uff0c\u516c\u53f8\u5c06\u786e\u5b9a\u9002\u54082 \/ 3\u671f\u8bbe\u8ba1\u7684\u6700\u4f73\u7ed9\u836f\u9014\u5f84\u548c\u5242\u91cf\u7ec4\u5408\u3002<\/p>\n

\u8be5\u75ab\u82d7Ib\u671f\u3001\u5f00\u653e\u6807\u7b7e\u3001\u5242\u91cf\u8303\u56f4\u7814\u7a76\u7684\u524d\u4e24\u7ec4\u53d7\u8bd5\u8005\u63a5\u53d7\u4e24\u79cd\u4e0d\u540c\u5242\u91cf\uff080.5\u548c1\u6beb\u5347\uff09\u7684\u76ae\u4e0b\u6ce8\u5c04\uff0c\u95f4\u969421\u5929\u3002<\/p>\n

\u53e6\u5916\u4e00\u7ec4\u670940\u540d\u53d7\u8bd5\u8005\uff0c\u4ee5\u8bc4\u4f30\u5728\u56db\u4e2a\u4e0d\u540c\u7684\u5c0f\u7ec4\u4e2d\u63a5\u53d7\u820c\u4e0b\u548c\u76ae\u4e0b\u5236\u5242\u7684hAd5\u7ec4\u5408\u7684\u7597\u6548\u3002<\/p>\n

\u7b2c\u4e8c\u98791b\u671f\u8bd5\u9a8c\u5c06\u662f\u4e00\u9879\u56db\u7ec4\u961f\u5217\u7814\u7a76\uff0c\u9884\u8ba1\u5c06\u4e8e2021\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5f00\u59cb\uff0c\u53d7\u8bd5\u8005\u591a\u8fbe65\u4eba\u3002<\/p>\n

12\u6708\uff0cNantKwest\u5ba3\u5e03\u4e0eImmunityBio\u8fbe\u6210\u5408\u5e76\u534f\u8bae\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

G1 Therapeutics\u5927\u6da816.9% G1 Therapeutics(NASDAQ:GTHX)\u76d8\u540e\u5927\u6da8 […]<\/p>\n","protected":false},"author":9,"featured_media":369813,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,747,925,459],"class_list":["post-369819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/369819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=369819"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/369819\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/369813"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=369819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=369819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=369819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}